Markets:

Overview

News

Currencies

International

Treasuries

Eli Lilly (NY:LLY)

1,180.16 -27.11 (-2.25%)

Official Closing Price Updated: 7:00 PM EDT, Aug 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

The GLP-1 Boom Created a Tissue Gap Fillers Were Not Built For

August 12, 2026

News Provided by USA News Group on behalf of Conexeu Sciences Inc.

From USA News Group

Via GlobeNewswire

Billions Flow Into Next-Generation Depression Treatments as Pharma Innovation Accelerates

July 21, 2026

EQNX::TICKER_START (NASDAQ:HELP),(NASDAQ:CMPS),(NASDAQ:ATAI),(NYSE:JNJ),(NYSE:LLY) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Artificial Intelligence

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AtaiBeckley Inc. (Nasdaq – ATAI), Distribution Solutions Group, Inc. (Nasdaq – DSGR), Cross Country Healthcare, Inc. (Nasdaq – CCRN), Nuvalent, Inc. (Nasdaq – NUVL)

July 16, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

As Medicare’s New GLP-1 Coverage Begins, Ozari Health Publishes 2026 Guide Comparing Every Way to Get Semaglutide and Tirzepatide – From $50 Copays to $86 Cash-Pay Options

July 15, 2026

Via AB Newswire

Dr. Danielle Carrera’s Beyond Better, Thrive Debuts as Amazon #1 New Release and Top 5 Bestseller

July 03, 2026

Via Get News

A Nasdaq-Listed Regenerative Tissue Company Just Opened a Lab: The Next Step in Scaling a Platform Built for a NEW Aesthetics Opportunity

July 01, 2026

From Biotech Insider

Via GlobeNewswire

WSTPR Catalyst Watch: Abu Dhabi Regulatory Clearance Adds Momentum to NeOnc's Global Neuro-Oncology Strategy

June 22, 2026

Houston, Texas--(Newsfile Corp. - June 22, 2026) - NeOnc Technologies Holdings (NASDAQ: NTHI) recently achieved what many biotechnology companies spend...

Via Newsfile

GeoVax CEO Highlights Renewed Strategic Interest in Vaccine Platforms and Infectious Disease Innovation

June 03, 2026

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

GeoVax CEO Highlights Renewed Strategic Interest in Vaccine Platforms and Infectious Disease Innovation

June 03, 2026

Recent Industry Activity Reinforces the Need for Manufacturing Resilience, Diversified Vaccine Supply, and Health Security Amid an Evolving Global Biothreat Landscape

Via TheNewswire.com

Peptide-Based Health Industry Positioned for Explosive Long-Term Growth Across Global Wellness Markets

May 21, 2026

EQNX::TICKER_START (OTCQB:PNGAF),(CSE:BPC),(NYSE:MMA),(NYSE:NVO),(NYSE:HIMS),(NYSE:LLY) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Government

Peptide-Based Health Industry Positioned for Explosive Long-Term Growth Across Global Wellness Markets

May 21, 2026

Analysts project billions in future market value as biotech innovation and consumer demand continue driving the next wave of health performance products

From MarketNewsUpdates.com

Via GlobeNewswire

Peptide Wellness Market Could Near $300 Billion as Consumer Demand Accelerates

May 12, 2026

EQNX::TICKER_START (OTCQB:PNGAF),(CSE:BPC),(NYSE:PFE),(NYSE:NVO),(NYSE:HIMS),(NYSE:LLY) EQNX::TICKER_END

Via FinancialNewsMedia

Peptide Wellness Market Could Near $300 Billion as Consumer Demand Accelerates

May 12, 2026

Next-generation wellness platforms targeting longevity, metabolism, and performance continue gaining momentum in one of healthcare’s fastest-growing sectors

From MarketNewsUpdates.com

Via GlobeNewswire

BioMedNewsBreaks — SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Advances Next-Generation GLP-1 Candidate as Obesity Drug Market Expands Rapidly

May 11, 2026

Via Investor Brand Network

The Next Generation of the GLP-1 Revolution Is Already Underway

May 11, 2026

Via Investor Brand Network

The Next Generation of the GLP-1 Revolution Is Already Underway

May 11, 2026

From BioMedWire

Via GlobeNewswire

Phase III Trial Enrollment Reached (75%) for Promising Anti-Inflammatory and Anti-Fibrotic Cardiac Therapies by Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL)

April 29, 2026

Via Get News

Topics Intellectual Property

Correction: Positive Results on MAVERIC Phase 2 and Published ARCHER Study Presented by the Company CEO in Live Interview with Barchart: Cardiol Therapeutics Inc. (NASDAQ: CRDL)

April 27, 2026

Via Get News

Topics Intellectual Property

Expert Matchmaker in Indianapolis Report by CX Research Institute

April 24, 2026

Via AB Newswire

Topics Economy

The Longevity Trade Is No Longer a Buzzword — It's a $120 Billion Market, and the FDA Just Cleared the First Cellular Rejuvenation Trial

April 23, 2026

From stem cell therapies for frailty to α-Klotho protein programs and GLP-1 drug classes now labeled "longevity therapeutics," the science and the capital have finally met

From Equity Insider

Via GlobeNewswire

$30 Billion Per Year US Heart Failure Market Presents Huge Opportunity for Promising Drugs Advancing with Positive Trial Results for Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL)

April 13, 2026

Via Get News

Topics Intellectual Property

ENDRA Life Sciences (NASDAQ: NDRA) Targets MASLD and GLP-1 Imaging Bottleneck With TAEUS® as Stocks Under $5 Gain Attention Inside

April 07, 2026

Via AB Newswire

Lexaria Applauds Eli Lilly's Foundayo(TM) Drug Approval

April 07, 2026

The number of oral weight-loss / diabetes drug treatments is expanding, increasing demand for the reduction of side effects

Via TheNewswire.com

Renovations and Equipment Upgrades Fell 18% in February 2026; Other Capital Projects Remain Stable

March 05, 2026

JACKSONVILLE BEACH, Fla., March 5, 2026 (SEND2PRESS NEWSWIRE) -- Industrial SalesLeads released its February 2026 Planned Capital Project Spending Report for the Industrial Manufacturing sector. The...

Via Send2Press

TinyGemsBreaks – Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) Appoints Dr. Freda Lewis-Hall to Board and Scientific Advisory Committee Chair

February 24, 2026

Via Investor Brand Network

Helus Pharma Appoints Former Pfizer Chief Medical Officer Dr. Freda Lewis-Hall to Board of Directors & Chair of the Scientific Advisory Committee

February 24, 2026

In this role, Dr. Lewis-Hall will guide clinical development strategy, regulatory engagement, and translational rigor across Helus’ novel serotonergic agonist (“NSA”) portfolio This news release...

Via FinancialNewsMedia

ELI LILLY AND COMPANY INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Eli Lilly and Company’s Directors and Officers for Breach of Fiduciary Duties – LLY

February 05, 2026

From Scott+Scott Attorneys at Law LLP

Via Business Wire

Veteran Biopharma Engineer Ge Yang Attracts Investor Interest with Vision to Redefine Global Pharma Manufacturing

February 03, 2026

Via AB Newswire

VenHub Appoints Former Amazon Executive, Ian Rasmussen, to Spearhead Nationwide Smart Store Expansion with Focus on Strategic Partnerships and Enterprise Integrations

February 02, 2026

VenHub Global, Inc. (NASDAQ:VHUB) (“VenHub” or the “Company”), a leader in fully autonomous Smart Store technology, today announced the appointment of Ian Rasmussen as

Via PressReach

Carvina Capital: Strong Demand Lifts Aktis IPO

January 27, 2026

Via AB Newswire

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.